Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:330-332
doi: 10.1161/01.STR.0000054048.22626.B9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldberg, M. P.
Right arrow Articles by Ransom, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldberg, M. P.
Right arrow Articles by Ransom, B. R.

(Stroke. 2003;34:330.)
© 2003 American Heart Association, Inc.


Advances in Stroke 2002

New Light on White Matter

Mark P. Goldberg, MD Bruce R. Ransom, MD

From the Center for the Study of Nervous System Injury (M.P.G.), Department of Neurology, Washington University School of Medicine, St. Louis, Mo, and the Department of Neurology (B.R.R.), University of Washington School of Medicine, Seattle, Wash.

Correspondence to Mark P. Goldberg, MD, Center for the Study of Nervous System Injury, Department of Neurology, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8111, St. Louis, MO 63110. E-mail goldberg@neuro.wustl.edu


Key Words: axons • ischemia • magnetic resonance imaging • oligodendrocyte • white matter


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Injury of central white matter is a major cause of functional disability in cerebrovascular disease. White matter is a target of hypoxic-ischemic injury throughout life, in clinical settings ranging from periventricular leukomalacia in the neonatal period, stroke and cardiac arrest in adults, to vascular dementia in the aging brain. The traditional view from animal studies is that gray matter is more vulnerable than white matter to ischemia.1 In part, this view may be an artifact of how ischemic brain injury has been studied. Most experimental work has used rodents, in which white matter constitutes only about 14% of total brain volume; in man, white matter is about 50% of brain volume.2 In fact, the metabolic rate of white matter is only modestly lower than that of gray matter,3 and recent animal studies suggest that white matter can be damaged even by brief ischemia.4 Moreover, clinical experience teaches that human ischemic stroke is almost never confined to gray matter. White matter is damaged by infarction in the territory of small vessels which perfuse centrum semiovale and deeper fiber pathways, and it is also damaged by occlusion of the large intracranial arteries which supply superficial gray and white matter together. Disruption of central conduction pathways may cause disruption of motor and sensory function, neurobehavioral syndromes,5 and cognitive impairment.6,7 Lacking neuronal cell bodies, dendrites, or synapses, white matter is unlikely to be injured by many of the mechanisms defined specifically in gray matter. Along with growing recognition of the importance of white matter . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. Matute, I. Torre, F. Perez-Cerda, A. Perez-Samartin, E. Alberdi, E. Etxebarria, A. M. Arranz, R. Ravid, A. Rodriguez-Antiguedad, M. Sanchez-Gomez, et al.
P2X7 Receptor Blockade Prevents ATP Excitotoxicity in Oligodendrocytes and Ameliorates Experimental Autoimmune Encephalomyelitis
J. Neurosci., August 29, 2007; 27(35): 9525 - 9533.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Kario, J. Ishikawa, S. Hoshide, Y. Matsui, M. Morinari, K. Eguchi, S. Ishikawa, and K. Shimada
Diabetic Brain Damage in Hypertension: Role of Renin-Angiotensin System
Hypertension, May 1, 2005; 45(5): 887 - 893.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. C. Kruit, M. A. van Buchem, P. A. M. Hofman, J. T. N. Bakkers, G. M. Terwindt, M. D. Ferrari, and L. J. Launer
Migraine as a Risk Factor for Subclinical Brain Lesions
JAMA, January 28, 2004; 291(4): 427 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. V. Sanchez-Gomez, E. Alberdi, G. Ibarretxe, I. Torre, and C. Matute
Caspase-Dependent and Caspase-Independent Oligodendrocyte Death Mediated by AMPA and Kainate Receptors
J. Neurosci., October 22, 2003; 23(29): 9519 - 9528.
[Abstract] [Full Text] [PDF]